Cell Source, Inc.
Close on Oct 19, 2026
- Market cap
- $21.99M
- P/E (TTM)
- –
- Dividend yield
- –
About Cell Source
Pharmaceutical Preparations, SIC 2834
Cell Source, Inc. is a corporate entity organized under the laws of Nevada. The supplied annual report excerpt consists primarily of regulatory reporting identifiers, financial instruments, and accounting classifications, without disclosing information regarding specific commercial operations, products, services, operating segments, or customers.
According to the filing, the company maintains its principal executive offices at 57 West 57th Street, Suite 400, New York, New York. The text does not provide additional facts regarding the organization's physical footprint, facility count, or geographic distribution of operations.
Summary of the business section of Cell Source's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Cell Source, Inc.
- Headquarters
- New York, NY
- Address
- 57 West 57th Street, Suite 400 10019
- Phone
- (646) 612-7554
- Employees
- 1, Dec 31, 2013
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- CBIZ CPAs P.C., New York, NY
Stock & identifiers
- Ticker
- CLCS
- Exchange
- OTC
- Shares outstanding
- 68M, May 13, 2026
- Public float
- $25.63K, Jun 30, 2024
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 7-for-3, Aug 19, 2014
- SEC CIK
- 1569340
- EIN
- 32-0379665
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Cell Source's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings